XOMA Royalty (XOMA) EBITDA Margin (2011 - 2026)

XOMA Royalty's (XOMA) quarterly EBITDA Margin came in at 3.87% in Q1 2026, down 15217.0% year-on-year from N/an in Q1 2025, and up 34.03% quarter-over-quarter from 5.87% in Q4 2025.

XOMA Royalty (XOMA) EBITDA Margin (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed EBITDA Margin across 16 years of filings, most recently posting 3.87% for Q1 2026.

  • EBITDA Margin for Q1 2026 came in at 3.87%, down 15217.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.47% (up 1064.0% YoY), and the FY2025 annual result was 12.83%, up 15313.0% from the prior year.
  • EBITDA Margin came in at 3.87% for Q1 2026 at XOMA Royalty, up from 5.87% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 318.11% in Q2 2024 to a low of 62548.0% in Q3 2024.
  • The 5-year median for EBITDA Margin is 576.85% (2024), against an average of 4193.24%.
  • Across the five-year window, EBITDA Margin slumped 6188427 bps in 2024 and surged 6195778 bps in 2025, its largest moves.
  • XOMA Royalty's EBITDA Margin stood at 402.15% in 2022, then plunged by 173 bps to 1097.05% in 2023, then plunged by 32 bps to 1450.2% in 2024, then soared by 100 bps to 5.87% in 2025, then surged by 34 bps to 3.87% in 2026.
  • The last three EBITDA Margin figures came in at 3.87% (Q1 2026), 5.87% (Q4 2025), and 590.22% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 38.10%
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - -3.87%

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.87%
Dec 31, 2025 -5.87%
Sep 30, 2025 -590.22%
Jun 30, 2025 91.66%
Mar 31, 2025 148.30%
Dec 31, 2024 -1,450.20%
Sep 30, 2024 -62,548.00%
Jun 30, 2024 318.11%
Mar 31, 2024 -576.85%
Dec 31, 2023 -1,097.05%
Sep 30, 2023 -663.73%
Jun 30, 2023 -784.88%
Mar 31, 2023 -2,245.54%
Dec 31, 2022 -402.15%
Sep 30, 2022 -926.39%
Jun 30, 2022 -475.08%
Mar 31, 2022 -73.38%
Dec 31, 2021 14,922.00%
Sep 30, 2021 -471.91%
Jun 30, 2021 -248.28%